Espinoza Stefano, Lignani Gabriele, Caffino Lucia, Maggi Silvia, Sukhanov Ilya, Leo Damiana, Mus Liudmila, Emanuele Marco, Ronzitti Giuseppe, Harmeier Anja, Medrihan Lucian, Sotnikova Tatyana D, Chieregatti Evelina, Hoener Marius C, Benfenati Fabio, Tucci Valter, Fumagalli Fabio, Gainetdinov Raul R
Department of Neuroscience and Brain Technologies, Istituto Italiano di Tecnologia, Genova, Italy.
Dipartimento di Scienze Farmacologiche e Biomolecolari, Università degli Studi di Milano, Milan, Italy.
Neuropsychopharmacology. 2015 Aug;40(9):2217-27. doi: 10.1038/npp.2015.65. Epub 2015 Mar 9.
Trace Amine-Associated Receptor 1 (TAAR1) is a G protein-coupled receptor expressed in the mammalian brain and known to influence subcortical monoaminergic transmission. Monoamines, such as dopamine, also play an important role within the prefrontal cortex (PFC) circuitry, which is critically involved in high-o5rder cognitive processes. TAAR1-selective ligands have shown potential antipsychotic, antidepressant, and pro-cognitive effects in experimental animal models; however, it remains unclear whether TAAR1 can affect PFC-related processes and functions. In this study, we document a distinct pattern of expression of TAAR1 in the PFC, as well as altered subunit composition and deficient functionality of the glutamate N-methyl-D-aspartate (NMDA) receptors in the pyramidal neurons of layer V of PFC in mice lacking TAAR1. The dysregulated cortical glutamate transmission in TAAR1-KO mice was associated with aberrant behaviors in several tests, indicating a perseverative and impulsive phenotype of mutants. Conversely, pharmacological activation of TAAR1 with selective agonists reduced premature impulsive responses observed in the fixed-interval conditioning schedule in normal mice. Our study indicates that TAAR1 plays an important role in the modulation of NMDA receptor-mediated glutamate transmission in the PFC and related functions. Furthermore, these data suggest that the development of TAAR1-based drugs could provide a novel therapeutic approach for the treatment of disorders related to aberrant cortical functions.
痕量胺相关受体1(TAAR1)是一种G蛋白偶联受体,在哺乳动物大脑中表达,已知其会影响皮层下单胺能传递。单胺类物质,如多巴胺,在前额叶皮质(PFC)神经回路中也发挥着重要作用,而该神经回路在高级认知过程中起着关键作用。TAAR1选择性配体在实验动物模型中已显示出潜在的抗精神病、抗抑郁和促认知作用;然而,TAAR1是否能影响与PFC相关的过程和功能仍不清楚。在本研究中,我们记录了TAAR1在PFC中的独特表达模式,以及在缺乏TAAR1的小鼠PFC第V层锥体神经元中谷氨酸N-甲基-D-天冬氨酸(NMDA)受体的亚基组成改变和功能缺陷。TAAR1基因敲除小鼠中失调的皮质谷氨酸传递与多项测试中的异常行为有关,表明突变体具有持续和冲动的表型。相反,用选择性激动剂对TAAR1进行药理学激活可减少正常小鼠在固定间隔条件反射实验中观察到的过早冲动反应。我们的研究表明,TAAR1在调节PFC中NMDA受体介导的谷氨酸传递及相关功能方面发挥着重要作用。此外,这些数据表明,开发基于TAAR1的药物可为治疗与异常皮质功能相关的疾病提供一种新的治疗方法。